Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Jonsson Comprehensive Cancer Center174 enrolled

Overview

Patients diagnosed with ocular melanoma consent to participate in the study. Combined PET/CT scans of the whole body are performed at baseline, three months later, and six months after that for a total of three combined scans in the first year. Subsequently, these combined scans will be performed at 6-monthly intervals for a total of two combined scans per year.

Study Type

OBSERVATIONAL

Enrollment

174

Conditions

Ocular Melanoma Choroidal Melanoma Uveal Melanoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients with a diagnosis of ocular melanoma (a pigmented malignant tumor) involving the choroid and/or ciliary body (the blood vessel layer in the back of the eye and/or the part of the eye behind the iris). 2. Patients 18 years of age or older. 3. Patients able to give informed consent. Exclusion Criteria: 1. Patients who refuse to participate in the study. 2. Patients who are unable to cooperate with or cannot undergo PET/CT scanning. 3. Patients who will be moving out of the area of UCLA during the ten years of this study.

Locations (1)

Jules Stein Eye Institute

Los Angeles, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.